Background

Dr Debra ten Brink completed her Master of Public Health at Imperial College London with a focus on global health and health economics after completing her medical degree. Before joining the Burnet Institute, she was a consultant for the WHO’s Global Malaria Programme involved in identifying methods to include cost-effectiveness and value for money in the evaluation of new preventive measures for malaria.

Debra now works with the Optima Consortium for Decision Science within the Burnet Institute to support cost-effective decision-making in global health. She works primarily with allocative efficiency models for HIV/AIDS, tuberculosis, malaria, nutrition, and maternal and child health, that have been applied in over 50 countries globally.

Positions

• 2017-2018: Consultant to the World Health Organization’s (WHO) Global Malaria Programme (GMP)
• 2016: Medical Doctor at Eurocross, the Netherlands

Qualifications

• 2017: Master of Public Health, Imperial College London, UK
• 2015: Master of Science in Medicine, Vrije Universiteit Amsterdam, the Netherlands
• 2011: Bachelor of Science in Medicine, Vrije Universiteit Amsterdam, the Netherlands

Projects (5)

Current (5)

• 

  Decision science using Optima

• 

  Optima HIV Modelling

• 

  Optima Malaria Modelling

• 

  Optima Nutrition Modelling

• 

  Optima Tuberculosis (TB) Modelling

Publications (6)

2022 (3)

• Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models.
  Bershteyn A, Jamieson L, Kim HY, Platais I, Milali MP, Mudimu E, Ten Brink D, Martin-Hughes R, Kelly SL, Phillips AN, Bansi-Matharu L, Cambiano V, Revill P, Meyer-Rath G, Nichols BE
  Lancet Glob Health. 2022 Sep; 10(9):e1298-e1306
• Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study.
  Ten Brink DC, Martin-Hughes R, Minnery ME, Osborne AJ, Schmidt HA, Dalal S, Green KE, Ramaurtarsing R, Wilson DP, Kelly SL
  PLoS One. 2022 May; 17(5):e0268240
• Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
  Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V; HIV Modelling Consortium.
  Lancet HIV. 2022 May; 9(5):e353-e362

2020 (1)

• Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
  Jewell BL, Mudimu E, Stover J, Ten Brink D, Phillips AN, Smith JA, Martin-Hughes R, Teng Y, Glaubius R, Mahiane SG, Bansi-Matharu L, Taramusi I, Chagoma N, Morrison M, Doherty M, Marsh K, Bershteyn A, Hallett TB, Kelly SL; HIV Modelling Consortium
  Lancet HIV. 2020 Aug; 7(9):e929-e940

2019 (1)

• What is the impact of a 20% funding cut in international HIV aid from the United States?
  Ten Brink D, Martin-Hughes R, Kelly SL, Wilson DP
  AIDS. 2019 Jul; 33(8):1406-1408

2018 (1)

• Malaria innovations: pursuing value in an evolving market.
  Debra Ten Brink, Mohamed Gad, Francis Ruiz
  Lancet Glob Health. 2018 Feb; 6(2):e138-e139

News Articles (1)

2019 (1)

• Burnet at Midsumma